SOLARIS VACCINES, INC.
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.3Mattributed |
|---|---|
| Latest round | grant, $1.3M, 2025-01-01attributed |
| Founded | unknown |
| Headquarters | Fort Collins, Colorado, USA |
| Industry | healthtech |
| Stage | unknown |
| Website | solarisvax.com |
SBIR Phase II award from Department of Defense (Defense Health Agency): VacciRAPTOR: High-throughput, Continuous Flow-Through System for Psoralen-UVA Inactivation
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | grant | $1.3M | undisclosed |
Detected tech stack
PHP, All in One SEO 4.9.7.2, All in One SEO Pack 4.9.7.2, Apache HTTP Server, MonsterInsights 10.2.0, Underscore.js 1.13.8, Google Analytics, Google Tag Manager, Flying Pages 2.4.7, Font Awesome, jQuery Migrate 3.4.1, Elementor 4.0.9
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $1.3M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.3M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | solarisvax.com, read 2026-05-08 |
| Description | self-reported | solarisvax.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.